Is Preoperative Prediction of Intra-Abdominal Adhesions Possible?

Last updated: October 10, 2024
Sponsor: Celal Bayar University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Surgery

Treatment

N/A

Clinical Study ID

NCT06639906
MCBU-Adhesion
  • Ages 18-50
  • Female

Study Summary

In this study, it was aimed to evaluate the presence of intra-abdominal adhesion with biochemical markers before the operation, as well as to determine whether there is a relationship between the severity of adhesion and preoperative blood decorin and TGF β1 levels by examining intra-abdominal adhesions histopathologically.This study was conducted on patients who were hospitalized in the department of gynecology and obstetrics of our hospital between 01.09.2023 and 01.09.2024 (1 year) with laparotomy or laparoscopic abdominal surgery planned for gynecological reasons and who had at least 1 previous cesarean section or a history of previous abdominal surgery (laparoscopy or laparotomy). will be made among patients.

The study is voluntary and patients who meet the appropriate criteria will be informed verbally and written consent will be obtained from the patients. Preoperative blood samples will be taken from each patient included in the study. Patients with no adhesions detected in the abdomen during the operation will constitute the control group, and patients with adhesions detected will constitute the study group. The number of patients is planned to be 26 patients in the case group and 28 patients in the control group. Tissue samples removed from detected intra-abdominal adhesions will be taken for histological examination. The tissue samples obtained will be subjected to routine light microscopy tissue monitoring and embedded in paraffin blocks, 5 micron sections will be taken with a microtome and will be examined with a light microscope after being stained with Hematoxylin Eosin. Adhesions detected intra-abdominally are according to the "peritoneal adhesion index" classification; It will be graded in 4 stages: 0: No adhesion, 1: Thin adhesions, blunt dissection, 2: Dense adhesions, sharp dissection, 3: Dense dense and vascularized adhesions, sharp dissection, injury that can be prevented with difficulty. Thanks to the grading of intra-abdominal adhesions, it will be possible to evaluate not only whether the parameters examined are predictive of intra-abdominal adhesions, but also which degree of adhesions they are more effective in predicting. Whether the presence of intra-abdominal adhesion is predictable will be determined by comparing the decorin and TGF β biomarker levels in preoperative blood samples with the decorin and TGF β immunohistochemistry results in the adhesion tissue.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients who are hospitalized for gynecological reasons with a planned laparotomy orlaparoscopic abdominal surgery

  • Patients with at least 1 previous cesarean section or history of previous abdominalsurgery (laparoscopy or laparotomy)

Exclusion

Exclusion Criteria:

  • Patients who do not agree to participate in the study will not be included in thestudy.

  • Pregnant patients will not be included in the study (so that the physiologicalchanges of pregnancy do not affect the results)

  • Presence of preoperative clinical or laboratory findings of infection (such as highfever, tachycardia, leukocytosis, high CRP)

  • Presence of hematological or coagulation disorders

  • History or presence of cancer treatment

  • History or presence of connective tissue disease

  • Presence of diabetes

  • Being under 18 years of age will be considered as exclusion criteria.

Study Design

Total Participants: 54
Study Start date:
January 14, 2024
Estimated Completion Date:
January 14, 2026

Connect with a study center

  • Manisa Celal Bayar University

    Manisa,
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.